More Epsilon Healthcare Limited news
Epsilon Healthcare LimitedASX: EPN

TGA GMP Manufacturing Licence Granted for Southport Facility

Jan 20, 2020 at 10:38 PM EST · Issued by Epsilon Healthcare Limited

Filed with ASX · Jan 20, 2020 at 10:38 PM EST · 2 pages · English

On 6ix: 6ix.com/news/tga-gmp-manufacturing-licence-granted-for-southport-facility

Epsilon Healthcare Limited on 6ix

Story so far

  • First Medicinal Cannabis Processed at Southport FacilityDec 4, 2019
  • Manufacturing Permit Received for Southport FacilityNov 11, 2019

Earlier from Epsilon Healthcare

  • Product Supply Agreement Signed with MGC PharmaJan 19, 2020
  • First Medicinal Cannabis Processed at Southport FacilityDec 3, 2019
  • THC Global Shareholder UpdateNov 19, 2019
  • Manufacturing Permit Received for Southport FacilityNov 10, 2019
  • THC Global Builds New Zealand CBD PresenceOct 20, 2019

Later from Epsilon Healthcare

  • Launch of Australian and International Medicines SupplyFeb 9, 2020
  • Production commenced to support 6000 Australian PatientsMar 2, 2020
  • Medicinal Cannabis Australian Release and Export UpdateApr 21, 2020
  • THC Global Secures $4m Debt FacilityApr 30, 2020
  • THC Global acquires leading clinic network Tetra HealthMay 12, 2020
All Epsilon Healthcare news releases↗

Follow Epsilon Healthcare into a list and get an email when it puts out news.

Follow Epsilon Healthcare
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer